Trial Profile
Randomized, double-blind, placebo-controlled study evaluating endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Apr 2018
Price :
$35
*
At a glance
- Drugs Conjugated estrogens/medroxyprogesterone (Primary) ; Conjugated estrogens
- Indications Endometrial hyperplasia; Menopausal syndrome
- Focus Adverse reactions
- Acronyms Woman's HOPE
- 20 Mar 2018 Results comparing REPLENISH and Woman's HOPE trials in terms of endometrial protection and uterine bleeding profile presented at The 100th Annual Meeting of the Endocrine Society
- 01 Jul 2001 New trial record.